Health Canada drug identification number

DIN 02462400 — BRINAVESS 20 MG

BRINAVESS is a solution of Vernakalant marketed by CIPHER PHARMACEUTICALS INC. The full Vernakalant monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02462400
Brand name
BRINAVESS
Active ingredient
Vernakalant
Strength
20 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
CIPHER PHARMACEUTICALS INC
Health Canada status
MARKETED
Drug class
Atrial-selective antiarrhythmic agent

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.